Cargando…
Lack of Association Between Neurohormonal Blockade and Survival in Transthyretin Cardiac Amyloidosis
BACKGROUND: Despite the belief that heart failure therapies are not effective in transthyretin cardiac amyloidosis, data are limited. We tested the association of neurohormonal blockade use with survival. METHODS AND RESULTS: A total of 309 consecutive patients with transthyretin cardiac amyloidosis...
Autores principales: | Cheng, Richard K., Vasbinder, Alexi, Levy, Wayne C., Goyal, Parag, Griffin, Jan M., Leedy, Douglas J., Maurer, Mathew S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075255/ https://www.ncbi.nlm.nih.gov/pubmed/34729989 http://dx.doi.org/10.1161/JAHA.121.022859 |
Ejemplares similares
-
Diuretic Dose and NYHA Functional Class Are Independent Predictors of Mortality in Patients With Transthyretin Cardiac Amyloidosis
por: Cheng, Richard K., et al.
Publicado: (2020) -
Transthyretin Cardiac Amyloidosis: Underrecognized in the Underrepresented
por: Leedy, Douglas J., et al.
Publicado: (2023) -
Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)
por: Damy, Thibaud, et al.
Publicado: (2019) -
Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis – Report from the Transthyretin Amyloidosis Outcome Survey (THAOS)
por: Kristen, Arnt V., et al.
Publicado: (2017) -
Analysis of disease progression in patients with transthyretin cardiac amyloidosis
por: Gilmore, Julian D, et al.
Publicado: (2015)